D-Valacyclovir

Catalog No. :
ACWDTJ014
CAS No. :
142963-60-8
Molecular Formula :
C13H20N6O4
Molecular Weight :
324.34

IUPAC Name:D-Valacyclovir

D-Valacyclovir structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameD-Valacyclovir
IUPAC NameD-Valacyclovir
Molecular FormulaC13H20N6O4
Molecular Weight324.34
SMILESN[C@H](C(C)C)C(OCCOCN1C=NC2=C1N=C(N)NC2=O)=O
InChI KeyHDOVUKNUBWVHOX-MRVPVSSYSA-N
SynonymValacyclovir EP Impurity R;D-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester (9CI);D-Valacyclovir (25 mg) (D-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy] ethyl ester);Valaciclovir Ep Impurity R;D-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester;D-Valacyclovir (D-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy] ethyl ester) (1707817);(R)-2-((2-amino-6-oxo-1H-purin-9(6H)-yl)methoxy)ethyl 2-amino-3-methylbutanoate;D-Valacyclovir
CAS No.142963-60-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACWDTJ014 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWDTJ014 route product structure diagram
    ACWDTJ014142963-60-8
Inquiry

2. ACWDTJ014 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJTPM169 route compound structure diagram
    ACJTPM169640-68-6 In Stock
  2. Plus
  3. ACEXDI096 route compound structure diagram
    ACEXDI09669657-51-8 In Stock
  4. Then
  5. ACWDTJ014 route product structure diagram
    ACWDTJ014142963-60-8
Inquiry

Comments (0)